Enoblituzumab (Anti-B7-H3 / CD276)Enoblituzumab (Anti-B7-H3 / CD276)
Move your mouse over image or click to enlarge

Enoblituzumab (Anti-B7-H3 / CD276)

Enoblituzumab (Anti-B7-H3 / CD276) is a humanized IgG1κ monoclonal antibody targeting human B7-H3 protein. It can be used in the treatment of medullary thyroid cancer (MTC). MW :150 KD.
Cat# Size Price Qty Buy
A2626-1mg*25 1mg*25
£2,432.00
A2626-1mg*5 1mg*5
£794.00
A2626-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2626

Related Documents